GENE ONLINE|News &
Opinion
Blog

Eye Disease
Pandorum Partners With Nucelion to Scale Exosome-Based Eye Therapies Across Asia-Pacific
2026-01-08
Roche Offers Up to $1 Billion for Avista to Develop Eye Disease Vectors
2022-07-20
Adverum Advances Wet AMD Gene Therapy After Cutting Jobs
2022-07-18
Belite Bio Clears Biopharma IPO Drought, with HilleVax and Tenon Medical Close Behind
2022-05-03
Birmingham University Spinout Looking to Tackle Ocular Surface Disorders
2022-04-26
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Backed by RTW, LENZ Therapeutics Inks $110 Vision Loss Pact with China’s JIXING
2022-04-14
Novartis Expands Optogenetics Portfolio By Acquiring Swiss Startup for an Undisclosed Amount
2021-09-21
AbbVie Strikes Gene Therapy Pact with REGENXBIO to Tackle Eye Diseases
2021-09-14
Oculis Raises $50 Million to Push Ophthalmic Portfolio and Expand International Foothold
2021-05-06
Roche’s Injectable Eye Medicine Lessens Treatment Burden in Two Diseases
2021-02-19
November 12, 1946: English Geneticist Veronica Van Heyningen was Born
2017-11-12
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top